Doxorubicin in relapsed soft tissue sarcoma: justification of phase II evaluation of new drugs in this disease. An EORTC Soft Tissue and Bone Sarcoma Group Study.
Blackledge
G
G
Department of Medicine, Queen Elizabeth Hospital, Birmingham, U.K.
van Oosterom
A
A
Mouridsen
H
H
Steward
W P
WP
Buesa
J
J
Thomas
D
D
Sylvester
R
R
Rouesse
J
J
D000328:Adult; D004317:Doxorubicin / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
D004317:Doxorubicin